WINTON GROUP Ltd - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 151 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$471,109
-28.9%
24,234
+3.8%
0.04%
-2.5%
Q1 2023$662,638
+14.7%
23,357
+18.1%
0.04%
+5.3%
Q4 2022$577,965
-29.5%
19,773
-36.3%
0.04%
-29.6%
Q3 2022$820,000
-14.4%
31,025
+43.9%
0.05%
+5.9%
Q2 2022$958,000
+18.6%
21,554
+32.0%
0.05%
+21.4%
Q1 2022$808,000
+56.6%
16,330
+61.2%
0.04%
+35.5%
Q4 2021$516,000
-54.9%
10,132
-50.6%
0.03%
-51.6%
Q3 2021$1,143,000
+9.2%
20,492
-16.2%
0.06%
+14.3%
Q2 2021$1,047,000
-6.5%
24,460
-8.9%
0.06%
-12.5%
Q1 2021$1,120,000
+41.2%
26,837
+57.6%
0.06%
+12.3%
Q4 2020$793,000
-36.6%
17,032
-42.2%
0.06%
+39.0%
Q3 2020$1,251,000
-77.9%
29,444
-75.0%
0.04%
-71.9%
Q2 2020$5,649,000
-13.1%
117,743
-16.7%
0.15%
-15.1%
Q1 2020$6,503,000
-29.8%
141,371
-8.3%
0.17%
+32.3%
Q4 2019$9,266,000
+2466.8%
154,224
+2318.8%
0.13%
+3150.0%
Q3 2019$361,000
+15.0%
6,376
+12.9%
0.00%
-33.3%
Q2 2019$314,000
-96.7%
5,646
-97.6%
0.01%
-97.1%
Q4 2018$9,552,000237,0800.21%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders